
Agenus Investor Relations Material
Latest events

Q4 2024
Agenus
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Agenus Inc
Access all reports
Agenus Inc. is a biotechnology company focused on the discovery and development of immunotherapies for cancer and other diseases. The company specializes in antibody-based therapies, including immune checkpoint inhibitors and personalized cancer vaccines. Agenus leverages its proprietary research platforms to develop novel treatments that enhance the body's immune response against tumors. Agenus Inc. is headquartered in Lexington, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
AGEN
Country
🇺🇸 United States